Adherence and reactogenicity to vaccines against sars-cov-2 in 285 patients with neuropathy: a multicentric study

HIGHLIGHTS

  • who: Salvatore Iacono and collaborators from the University of Palermo, Palermo, Italy have published the research work: Adherence and Reactogenicity to Vaccines against SARS-COV-2 in 285 Patients with Neuropathy: A Multicentric Study, in the Journal: (JOURNAL)
  • what: The aim of this study is to evaluate the adherence to SARS-CoV-2 vaccination as well as the reactogenicity to those vaccines in patients affected by neuropathy. The authors aim to explore whether the prevalence of AEs differs depending on gender, age, type of neuropathy, COVID-19 before vaccination, and medications assumption. When compared with . . .

     

    Logo ScioWire Beta black

    If you want to have access to all the content you need to log in!

    Thanks :)

    If you don't have an account, you can create one here.

     

Scroll to Top

Add A Knowledge Base Question !

+ = Verify Human or Spambot ?